Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)
Loading...
Date
2014
Authors
Fernández-Plana, Julen
Pericay, Carles
Quintero, Guillermo
Alonso, Vicente
Salud Salvia, Maria Antonieta
Méndez, Miguel
Salgado, Mercedes
Saigi, Eugeni
Cirera, Luis
Other authors
ACROSS Study Group
Impact
Export
Share
Journal Title
Journal ISSN
Volume Title
Related resource
Citation
Journal or Serie
BMC Cancer, 2017, vol. 14, p. 865